United States

Choose your country

Select to view the solutions available in your location.

Products and services

Products and services

Learn more about our innovative products and services that help detect cancer earlier and power smarter treatment decisions.
Explore our products

Cancer Risk Starts in the Genes

Exact Sciences is working to eradicate cancer by delivering a portfolio that gives providers the information they need to better serve their patients across the cancer care continuum — starting with familial risk.
Read more
Science

Science

Find out how our scientific rigor, quality standards, and development of future tests make us a leader in cancer testing and treatment guidance.
Explore our science

New England Journal of Medicine Publishes the Science Powering the Next-Generation Cologuard Test

Exact Sciences expects the test to be available in 2025, pending approval.
Read more
About

About

Learn all about Exact Sciences, including our purpose, the people who drive it, our history, and the impact we’ve made.
Learn more about us

Exact Sciences to Employees: ‘Go Volunteer on Work Time’

The company’s commitment to community involvement keeps paying off when employees get back from giving back.
Read more
News and events

News and events

Explore stories, news, and events that highlight our innovation, technology, and people fighting cancer on all fronts.
View news and events

FDA Approves Exact Sciences’ Cologuard Plus™ Test, Setting A New Benchmark in Non-Invasive Colorectal Cancer Screening
Read more
- Press releases
- For media

United States

Choose your country

Select to view the solutions available in your location.

Multimedia

Photos, Logos and Downloads

Complaint – Exact Sciences Files Patent Infringement Lawsuit Against Geneoscopy

Download
BLUE-C Study Top-line Findings

DOWNLOAD
The Harris Poll Survey Infographic

Many Americans are unaware of the risk of colorectal cancer based on new data from The Harris Poll. Read on to find out why screening is so important.

Download
Cologuard analyzes both DNA alterations and blood in the stool to detect the presence of colon cancer and precancers. With Cologuard, patients can provide a sample in the privacy of their own home.

Download
Corporate One-pager

Download
Cologuard is the first FDA-approved, noninvasive, stool-based DNA (sDNA) colorectal cancer screening test. Cologuard is intended for men and women 45 years or older at average risk for colorectal cancer.

Download
Exact Sciences Corporation logo image (PNG). Also available as SVG.

Download
Cologuard logo image.

Download
Oncotype DX logo image

Download
Exact Sciences Laboratories, Madison, WI

Download
Exact Sciences Laboratories, Madison, WI

Download
Exact Sciences Laboratories, Madison, WI

Download
Exact Sciences Laboratories, Madison, WI

Download
Exact Sciences Laboratories, Madison, WI

Download
Exact Sciences Laboratories, Madison, WI

Download
Exact Sciences Laboratories, Madison, WI

Download
Exact Sciences Laboratories, Madison, WI

Download
Precision Oncology Lab, Redwood City, CA

Download
Precision Oncology Lab, Redwood City, CA

Download
Precision Oncology Lab, Redwood City, CA

Download
Precision Oncology Lab, Redwood City, CA

Download
Precision Oncology Lab, Redwood City, CA

Download

Videos

Cologuard Classic

A highlight reel featuring Exact Sciences’ title sponsorship of this premier PGA TOUR Champions tournament.

Cologuard and Exact Sciences B-roll 2023

This package features b-roll from Exact Sciences Laboratories.

Animated Demonstration of Cologuard

An animated demonstration of the science behind Cologuard. No voiceover or SOTs.